Perceptive Advisors LLC 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-31 4:16 pm Purchase | 2024-10-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 547,935 14.200% | 2,090 (+0.38%) | Filing |
| 2023-12-29 5:15 pm Purchase | 2023-12-27 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 545,845 14.300% | 64,730 (+13.45%) | Filing |
| 2022-07-01 4:45 pm Purchase | 2022-06-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 481,115 12.800% | 138,523 (+40.43%) | Filing |
| 2021-02-08 5:16 pm Purchase | 2021-01-25 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 342,592 9.800% | 342,592 (New Position) | Filing |